US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 43.570
  • -0.070-0.16%
Close Dec 11 16:00 ET
  • 43.570
  • 0.0000.00%
Post 20:01 ET
2.09BMarket Cap14.48P/E (TTM)

About Amphastar Pharmaceuticals Company

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Company Profile

SymbolAMPH
Company NameAmphastar Pharmaceuticals
Listing DateJun 25, 2014
Issue Price7.00
Founded1996
CEODr. Jack Yongfeng Zhang
MarketNASDAQ
Employees1761
Fiscal Year Ends12-31
Address11570 6th Street
CityRancho Cucamonga
ProvinceCalifornia
CountryUnited States of America
Zip Code91730
Phone1-909-980-9484

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jack Yongfeng Zhang
  • Director, President, Chief Executive Officer and Chief Scientific Officer
  • 7.72M
  • Dr. Mary Ziping Luo
  • Chairman of the Board, Chief Operating Officer and Chief Scientist
  • 3.77M
  • William J. Peters
  • Director, Principal Accounting Officer, Chief Financial Officer, Executive Vice President, Finance and Treasurer; President of International Medication Systems, Limited
  • 2.89M
  • Rong Zhou
  • Senior Executive Vice President, Production Center, Executive Vice President, Scientific Affairs; President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
  • 2.03M
  • Jacob Liawatidewi
  • Director, Executive Vice President, Sales and Marketing and Corporate Administration Center and Corporate Secretary; President of Amphastar France Pharmaceuticals, S.a.S.
  • 1.78M
  • Gayle M. Deflin
  • Independent Director
  • 330.00K
  • Floyd F. Petersen, M.P.H.
  • Independent Director
  • 315.00K
  • Diane G. Gerst
  • Independent Director
  • 314.70K
  • Richard Prins
  • Lead Independent Director
  • 362.00K
  • Dr. Michael A. Zasloff, PhD
  • Independent Director
  • 321.00K
  • Dr. Howard S. Lee, PhD
  • Independent Director
  • 325.81K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.